As of 2026-08-24, American Shared Hospital Services (AMS) has a 3-month relative strength percentile of 60 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 42. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.0%, relative volume 0.23×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
AMS is in a stage 4 downtrend, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -4.2% / -20.1%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
AMS is held by 4 ETFs as of Apr 2026. Top owner: DFSV at 0.00% weight, $7K notional. Top 3 carry $14K.
Held by 7 ETFs · $254K across latest filings · largest weight 0.00% (VXF).
Top 4 by value, from SEC N-PORT-P filings dated Apr 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| DFSV | 0.00% | $7K | — |
| DFATDimensional U.S. Targeted Value ETF | 0.00% | $6K | — |
| DFSU | 0.00% | $197 | — |
| DFACDimensional U.S. Core Equity 2 ETF | 0.00% | $15 | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | AMS Jan avg: 4.79% median: 5.19% win: 75% σ: 7.47% n: 4 2022-04-12 → 2026-07-31 | AMS Feb avg: 2.61% median: 0.51% win: 50% σ: 8.23% n: 4 2022-04-12 → 2026-07-31 | AMS Mar avg: -12.80% median: -14.38% win: 25% σ: 18.14% n: 4 2022-04-12 → 2026-07-31 | AMS Apr avg: -0.50% median: -1.07% win: 40% σ: 2.32% n: 5 2022-04-12 → 2026-07-31 | AMS May avg: 0.86% median: 2.78% win: 80% σ: 7.14% n: 5 2022-04-12 → 2026-07-31 | AMS Jun avg: -2.07% median: -3.47% win: 40% σ: 6.92% n: 5 2022-04-12 → 2026-07-31 | AMS Jul avg: 0.65% median: 0.57% win: 60% σ: 4.64% n: 5 2022-04-12 → 2026-07-31 | AMS Aug avg: 4.15% median: 2.69% win: 75% σ: 6.70% n: 4 2022-04-12 → 2026-07-31 (current) | AMS Sep avg: -0.01% median: -2.44% win: 25% σ: 9.36% n: 4 2022-04-12 → 2026-07-31 | AMS Oct avg: -5.11% median: -2.05% win: 50% σ: 10.09% n: 4 2022-04-12 → 2026-07-31 | AMS Nov avg: 2.58% median: 2.13% win: 75% σ: 6.84% n: 4 2022-04-12 → 2026-07-31 | AMS Dec avg: -0.48% median: -0.48% win: 25% σ: 0.83% n: 4 2022-04-12 → 2026-07-31 |